Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to buy according to analysts. On December 19, TheFly reported that Cathie Wood’s ARK Investment has ...

This is the codebase for the paper: "Less is More: Recursive Reasoning with Tiny Networks". TRM is a recursive reasoning approach that achieves amazing scores of 45% on ARC-AGI-1 and 8% on ARC-AGI-2 ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

We present a pixel recursive super resolution model that synthesizes realistic details into images while enhancing their resolution. A low resolution image may correspond to multiple plausible high ...